Skanska signs an additional contract for cancer center in Livingston, New Jersey, USA, for USD 85M, about SEK 900M

Skanska has signed an additional contract with RWJBarnabas Health to build an ambulatory care cancer center in Livingston, New Jersey, USA. The additional contract is worth USD 85M, about SEK 900M, which will be included in the US order bookings for the third quarter 2023.

The five-story building on the Cooperman Barnabas Medical Center campus, totaling 13,000 square meters will provide outpatient cancer treatment. A parking garage will also be constructed.

Construction started in September 2022, and completion is scheduled towards the end of 2025.

For further information please contact:

Chris Mckniff, Communications Director, Skanska USA, tel +1 (347) 409 2719

Andreas Joons, Press Officer, Skanska AB, tel +46 (0)10 449 04 94

Direct line for media, tel +46 (0)10 448 88 99

This and previous releases can also be found at www.skanska.com.

Skanska Group uses knowledge & foresight to shape the way people live, work, and connect. Over 135 years in the making, we’re one of the world’s largest project development and construction companies, with 2022 revenue totaling SEK 162 billion. We operate across select markets in the Nordics, Europe and USA. Together with our customers and the collective expertise of our 28,000 teammates, we create innovative and sustainable solutions that support healthy living beyond our lifetime.